These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 6148880

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Use of a nonselective beta-blocker, nadolol, in the treatment of portal hypertension in cirrhotics.
    Gatta A, Sacerdoti D, Merkel C, Rossoni R, Finucci G, Bolognesi M, Zuin R.
    Int J Clin Pharmacol Res; 1985; 5(6):413-8. PubMed ID: 4093219
    [Abstract] [Full Text] [Related]

  • 3. Long-term effects of beta-adrenergic blockade with nadolol on hepatic and renal haemodynamics and function in cirrhotics.
    Gatta A, Bolognesi M, Merkel C, Finucci GF, Angeli P, Sacerdoti D, Ruol A.
    Clin Physiol; 1987 Oct; 7(5):377-87. PubMed ID: 3665396
    [Abstract] [Full Text] [Related]

  • 4. Pharmacologic prevention of variceal bleeding and rebleeding.
    Baiges A, Hernández-Gea V, Bosch J.
    Hepatol Int; 2018 Feb; 12(Suppl 1):68-80. PubMed ID: 29210030
    [Abstract] [Full Text] [Related]

  • 5. Effect of nadolol on liver haemodynamics and function in patients with cirrhosis.
    Merkel C, Sacerdoti D, Finucci GF, Zuin R, Bazzerla G, Bolognesi M, Gatta A.
    Br J Clin Pharmacol; 1986 Jun; 21(6):713-9. PubMed ID: 3741719
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Disagreement between acute and chronic haemodynamic effects of nadolol in cirrhosis: a pathophysiological interpretation.
    Merkel C, Bolognesi M, Sacerdoti D, Bombonato G, Cavasin L, Gatta A.
    Aliment Pharmacol Ther; 2005 Sep 01; 22(5):433-9. PubMed ID: 16128681
    [Abstract] [Full Text] [Related]

  • 11. Preventing the development of varices in cirrhosis.
    Garcia-Tsao G.
    J Clin Gastroenterol; 2007 Sep 01; 41 Suppl 3():S300-4. PubMed ID: 17975480
    [Abstract] [Full Text] [Related]

  • 12. Hemodynamic assessment of pharmacological response in the treatment of portal hypertension: a need to know.
    Grace ND.
    Am J Gastroenterol; 2000 Aug 01; 95(8):1862-4. PubMed ID: 10950027
    [No Abstract] [Full Text] [Related]

  • 13. Antihypertensive and renal haemodynamic effects of atenolol and nadolol in elderly hypertensive patients.
    O'Callaghan WG, Laher MS, McGarry K, O'Brien E, O'Malley K.
    Br J Clin Pharmacol; 1983 Oct 01; 16(4):417-21. PubMed ID: 6138058
    [Abstract] [Full Text] [Related]

  • 14. Maintenance of hemodynamic response to treatment for portal hypertension and influence on complications of cirrhosis.
    Villanueva C, López-Balaguer JM, Aracil C, Kolle L, González B, Miñana J, Soriano G, Guarner C, Balanzó J.
    J Hepatol; 2004 May 01; 40(5):757-65. PubMed ID: 15094222
    [Abstract] [Full Text] [Related]

  • 15. Long-term renal hemodynamic effects of nadolol in patients with essential hypertension.
    Frohlich ED, Messerli FH, Deslinski GR, Kobrin I.
    Am Heart J; 1984 Oct 01; 108(4 Pt 2):1141-3. PubMed ID: 6148875
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Use of esmolol in patient with portal hypertension].
    Figueroa Yusta J, Gilsanz F, De Dios Tomás E.
    Rev Esp Anestesiol Reanim; 2001 Oct 01; 48(7):349. PubMed ID: 11591288
    [No Abstract] [Full Text] [Related]

  • 19. Effects of the alpha-/beta-blocking agent carvedilol on hepatic and systemic hemodynamics in patients with cirrhosis and portal hypertension.
    Sekiyama T, Komeichi H, Nagano T, Ohsuga M, Terada H, Katsuta Y, Satomura K, Aramaki T.
    Arzneimittelforschung; 1997 Apr 01; 47(4):353-5. PubMed ID: 9150854
    [Abstract] [Full Text] [Related]

  • 20. [Effects of acute octreotide infusion on renal function in patients with cirrhosis and portal hypertension].
    Silva G, Segovia R, Backhouse C, Palma M, Márquez S, Iturriaga H.
    Rev Med Chil; 2004 Feb 01; 132(2):144-50. PubMed ID: 15449549
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.